Twice-weekly dapsone-pyrimethamine for preventing PCP and cerebral toxoplasmosis.
Clotet
B
B
Sirera
G
G
Romeu
J
J
Gimeno
J M
JM
Jou
A
A
Condom
M J
MJ
Tor
J
J
Foz
M
M
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D001927:Brain Diseases / Q000150:complications / Q000517:prevention & control*; D003622:Dapsone / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000150:complications; D006801:Humans; D008297:Male; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000517:prevention & control*; D011446:Prospective Studies; D011739:Pyrimethamine / Q000008:administration & dosage / Q000627:therapeutic use*; D014123:Toxoplasmosis / Q000150:complications / Q000517:prevention & control*
D003622:Dapsone; D011739:Pyrimethamine